Treprostinil (Parenteral/Inhaled)
Treatment for Pulmonary Arterial Hypertension
Effectiveness
90%
Safety Score
30%
Clinical Trials
1
Participants
8K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
30
DangerousModerateSafe
Treatment Details
0
Treprostinil (Parenteral/Inhaled) Outcomes
for Pulmonary Arterial Hypertension
Efficacy Outcomes
Overall Effectiveness
+90%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
1 completed trial for Treprostinil (Parenteral/Inhaled) in Pulmonary Arterial Hypertension
Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
NCT01268553COMPLETEDPHASE4
6 participants
INTERVENTIONAL
Tucson, United States +2 more
Started: Aug 1, 2010